SUPREME PHARMACEUTICALS INC.

Profile

Company Names

SUPREME PHARMACEUTICALS INC.

Addresses

202 - 20 DE BOERS DRIVE, TORONTO, A6 M3J 0H1

SUITE #430, 580 HORNBY STREET, VANCOUVER, A1 V6C 3B6

Phone Numbers

(416) 630-7272
604-674-2191

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$2,386,467.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2016-12-13 
$369,667.00 
$369,667.00 
$0.00 
Equity, Debt 
4
2015-04-23 
$1,212,649.00 
$1,212,649.00 
$0.00 
Equity, Debt 
3
2015-01-23 
$116,985.00 
$116,985.00 
$0.00 
Equity 
2
2014-11-05 
$538,049.00 
$538,049.00 
$0.00 
Equity 
1
2014-09-19 
$149,117.00 
$149,117.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS 
 
BECHTEL 
DIRECTOR
SUPREME PHARMACEUTICALS INC.   |  SURNA INC.   |  RAVENQUEST BIOMED INC.
CHRISTOPHER 
 
BECHTEL 
DIRECTOR
SUPREME PHARMACEUTICALS INC.
NAVDEEP 
 
DHALIWAL 
EXECUTIVE OFFICER, DIRECTOR
SUPREME PHARMACEUTICALS INC.
JOHN 
 
FOWLER 
EXECUTIVE OFFICER, DIRECTOR
SUPREME PHARMACEUTICALS INC.   |  TAI DIAGNOSTICS, INC.   |  PHARMACEUTICS INTERNATIONAL, INC.   |  INTRIGUE MEDIA INC.   |  MBODY AI CORP.
CAILIN 
 
GEHLSEN 
EXECUTIVE OFFICER
SUPREME PHARMACEUTICALS INC.
PETER 
 
HERBURGER 
EXECUTIVE OFFICER
SUPREME PHARMACEUTICALS INC.
TATIANA 
 
KOVALEVA 
EXECUTIVE OFFICER
SUPREME PHARMACEUTICALS INC.   |  360 BLOCKCHAIN INC.
MICHAEL 
 
LA BRIER 
DIRECTOR
SUPREME PHARMACEUTICALS INC.
ALLAN 
 
LEVIEN 
DIRECTOR
SUPREME PHARMACEUTICALS INC.
CHUCK 
 
RIFICI 
DIRECTOR
SUPREME PHARMACEUTICALS INC.   |  ONE WEB SERVICES, INC.
DAVID 
 
STADNYK 
EXECUTIVE OFFICER, DIRECTOR
EUPRAXIA PHARMACEUTICALS INC.   |  SUPREME PHARMACEUTICALS INC.   |  WORLD HIGH LIFE PLC
GEORGE 
 
TSAFALAS 
DIRECTOR
CANADIAN ENERGY EXPLORATION INC.   |  EUPRAXIA PHARMACEUTICALS INC.   |  SUPREME PHARMACEUTICALS INC.   |  QUIKFLO HEALTH INC.   |  360 BLOCKCHAIN INC.
SCOTT 
 
WALTERS 
DIRECTOR
COREOBJECTS SOFTWARE, INC.   |  SUPREME PHARMACEUTICALS INC.   |  MOLECULAR SCIENCE CORP   |  MBODY AI CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-03-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-12-13 
2015-05-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-04-23 
2015-02-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-23 
2014-11-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-19 
2014-11-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-05 
2014-10-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CANACCORD GENUITY INC.
1020
CANACCORD GENUITY CORP.
NONE
NONE
NONE
DUNDEE SECURITIES LTD.
NONE
NONE
NONE
BEACON SECURITIES LIMITED
NONE
NONE
NONE
CORMARK SECURITIES INC.
NONE
NONE
NONE
CANACCORD GENUITY CORP.
NONE
NONE
NONE
GLOBAL SECURITIES CORPORATION
NONE
NONE
NONE
GEORGE CALLAHAN
NONE
NONE
NONE
BARBARA FISHER
NONE